Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Drug Resistance”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02507921
What this trial is testing

Resistance in HIV+ in North and South

Who this might be right for
HIV Drug Resistance
Infectious Diseases Institute 2,750
Post-approval studies (Phase 4)Study completedNCT00187551
What this trial is testing

Pilot Study Evaluating Interruption of Enfuvirtide (Fuzeon, T20) in Patients With Enfuvirtide Resistance

Who this might be right for
HIV Infections
University of California, San Francisco 25
Not applicableStudy completedNCT02787499
What this trial is testing

Resistance Testing to Improve Management of Virologic Failure in Sub-Saharan Africa

Who this might be right for
HIVAIDS
Massachusetts General Hospital 840
Not applicableNot Yet RecruitingNCT06842706
What this trial is testing

Prevalence of Drug-resistant Hiv-1 Strains in Patients Experiencing Virologic Failure. (MULTIVIR2025)

Who this might be right for
HIV Infection
ANRS, Emerging Infectious Diseases 800
Not applicableStudy completedNCT05208671
What this trial is testing

Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma

Who this might be right for
HIVInsulin ResistanceFood Insecurity
University of Oklahoma 675
Not applicableStudy completedNCT01204814
What this trial is testing

HIV-1 Resistance at Screening for HIV Prevention Studies

Who this might be right for
HIV
Microbicide Trials Network 1,074
Not applicableStudy completedNCT02729532
What this trial is testing

Effect of Xpert MTB/RIF on Patient Outcomes

Who this might be right for
Tuberculosis
University of North Carolina, Chapel Hill 776
Not applicableStudy completedNCT00002094
What this trial is testing

Prospective Open-Label Study of the Emergence of Drug Resistance in Patients Infected With HIV-1 Who Are Taking Oral U-87201E

Who this might be right for
HIV Infections
Pharmacia and Upjohn
Not applicableStudy completedNCT00164762
What this trial is testing

Nevirapine Resistance Study: Nevirapine Resistance Among HIV-Infected Mothers

Who this might be right for
HIV Infections
Centers for Disease Control and Prevention 126
Not applicableStudy completedNCT00152061
What this trial is testing

The Switch Study: The Role of Lamivudine/Emtricitabine (3TC/FTC) in Antiretroviral Regimens

Who this might be right for
HIV Infections
Stanford University 40
Testing effectiveness (Phase 2)Study completedNCT00046033
What this trial is testing

Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 118
Not applicableStudy completedNCT00067106
What this trial is testing

Antiviral Therapy and HIV in the Female Genital Tract

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 130
Not applicableStudy completedNCT00006494
What this trial is testing

Study of Tests to Evaluate Effectiveness of Anti-HIV Drugs

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 14
Testing effectiveness (Phase 2)Study completedNCT00029341
What this trial is testing

Demonstrate That Anti-HIV Drug Therapy Can be Stopped Without Causing Viral Resistance, and to Characterize Drug Elimination From the Body

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Large-scale testing (Phase 3)Study completedNCT00162682
What this trial is testing

Monitoring Highly Active Antiretroviral Therapy in HIV-infected Parents in Thailand

Who this might be right for
HIV Infections
Institut de Recherche pour le Developpement 716
Not applicableStudy completedNCT00000796
What this trial is testing

A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 525
Not applicableStudy completedNCT03767374
What this trial is testing

Risk-factors for Multidrug-resistant Bacteria Colonization Among Patients at High Risk of STIs

Who this might be right for
Bacterial InfectionsHIV Infections
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 2,186
Not applicableLooking for participantsNCT05671718
What this trial is testing

Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB Treatment

Who this might be right for
Drug Resistant Tuberculosis
Johns Hopkins University 2,944
Post-approval studies (Phase 4)Study completedNCT03087890
What this trial is testing

Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria

Who this might be right for
HIV-1-infectionPneumocystis PneumoniaOpportunistic Infections+2 more
University of Bergen 537
Early research (Phase 1)Study completedNCT00001818
What this trial is testing

Combination Drug Treatment of Pediatric HIV Infection

Who this might be right for
HIV Infection
National Cancer Institute (NCI) 50
Next Page